Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
Udwadia, Zarir F., Singh, Pawan, Barkate, Hanmant, Patil, Saiprasad, Rangwala, Shabbir, Pendse, Amol, Kadam, Jatin, Wu, Wen, Caracta, Cynthia F., Tandon, Monika
Published in International journal of infectious diseases (01.02.2021)
Published in International journal of infectious diseases (01.02.2021)
Get full text
Journal Article
Response to the comments received on article “Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial” by Udwadia et al
Udwadia, Zarir F., Barkate, Hanmant, Patil, Saiprasad, Rangwala, Shabbir, Wu, Wen, Caracta, Cynthia F., Tandon, Monika
Published in International journal of infectious diseases (01.04.2021)
Published in International journal of infectious diseases (01.04.2021)
Get full text
Journal Article
Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to-severe COPD
Salvi, Sundeep, Jain, Manish, Krishnamurthy, Srikanth, Balki, Akash, Kodgule, Rahul, Tandon, Monika, Bhagat, Sagar, Panchal, Sagar, Khatri, Nishtha, Wu, Wen, Pendse, Amol, Patil, Saiprasad, Barkate, Hanmant
Published in Lung India (01.11.2022)
Published in Lung India (01.11.2022)
Get full text
Journal Article
Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial
Salvi, Sundeep, Balki, Akash, Krishnamurthy, Srikanth, Panchal, Sagar, Patil, Saiprasad, Kodgule, Rahul, Khandagale, Hitesh, Pendse, Amol, Wu, Wen, Rangwala, Shabbir, Tandon, Monika, Barkate, Hanmant
Published in ERJ open research (01.07.2021)
Published in ERJ open research (01.07.2021)
Get full text
Journal Article
Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: A single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers
Iqbal, Muzaffar, PhD, Khuroo, Arshad, PhD, Batolar, Lakhvinder S., PhD, Tandon, Monika, MD, DM, Monif, Tausif, PhD, Sharma, P.L., MD, PhD
Published in Clinical therapeutics (01.03.2010)
Published in Clinical therapeutics (01.03.2010)
Get full text
Journal Article
A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers
Monif, Tausif, PhD, Rao Thudi, Nageshwar, BPharm, Koundinya Tippabhotla, Sudhakar, MPharm, Khuroo, Arshad, MPharm, Marwah, Amit, MBBS, Kumar Shrivastav, Vikesh, MSc, Tandon, Monika, DM, Raghuvanshi, Rajeev, PhD, Biswal, Shibadas, MD
Published in Clinical therapeutics (01.12.2007)
Published in Clinical therapeutics (01.12.2007)
Get full text
Journal Article
Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function
Jain, Sunil M, Balamurugan, Ramanathan, Tandon, Monika, Mozaffarian, Neelufar, Gudi, Girish, Salhi, Yacine, Holland, Robert, Freeman, Roy, Baron, Ralf
Published in Pain (Amsterdam) (01.06.2022)
Published in Pain (Amsterdam) (01.06.2022)
Get full text
Journal Article
In vivo phenotyping of cytochrome 450 isoforms involved in the metabolism of anti-HIV and anti-tubercular drugs in human using cocktail approach: An LC–MS/MS analysis
Varshney, Ekta, Tandon, Monika, Saha, Nilanjan, Ali, Shakir
Published in Journal of pharmaceutical and biomedical analysis (05.02.2019)
Published in Journal of pharmaceutical and biomedical analysis (05.02.2019)
Get full text
Journal Article
Randomized, Double-blind, Phase III Trial of Lobeglitazone Add-on to Metformin in Type 2 Diabetes (SENSITIZE INDIA)
Joshi, Shashank, Tandon, Monika, Kodgule, Rahul, Wu, Wen, Jadhao, Vibhuti, Suryawanshi, Sachin, Barkate, Hanmant
Published in Journal of the Association of Physicians of India (01.01.2024)
Published in Journal of the Association of Physicians of India (01.01.2024)
Get full text
Journal Article
800-P: Phase 3 Results of Fixed-Dose Combination of Remogliflozin Etabonate and Vildagliptin in Indian T2DM Patients
MOHAN, BRIJ, CHAWLA, MANOJ S., KODGULE, RAHUL R., TANDON, MONIKA, KATARE, SAGAR, SURYAWANSHI, SACHIN, BARKATE, HANMANT V.
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial
Dharmalingam, Mala, Aravind, S. R., Thacker, Hemant, Paramesh, S., Mohan, Brij, Chawla, Manoj, Asirvatham, Arthur, Goyal, Ramesh, Shembalkar, Jayashri, Balamurugan, R., Kadam, Pradnya, Alva, Hansraj, Kodgule, Rahul, Tandon, Monika, Vaidyanathan, Sivakumar, Pendse, Amol, Gaikwad, Rajesh, Katare, Sagar, Suryawanshi, Sachin, Barkate, Hanmant
Published in Drugs (New York, N.Y.) (01.04.2020)
Published in Drugs (New York, N.Y.) (01.04.2020)
Get full text
Journal Article
Abstract 165: Study of lobeglitazone for evaluation of safety and efficacy with active comparator pioglitazone in Indian T2DM patients: A randomized phase III trial (sensitize India)
Joshi, Shashank, Jadhao, Vibhuti, Kodgule, Rahul, Tandon, Monika, Suryawanshi, Sachin, Barkate, Hanmant
Published in Indian journal of endocrinology and metabolism (01.12.2022)
Published in Indian journal of endocrinology and metabolism (01.12.2022)
Get full text
Journal Article
SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial
Tandon, Monika, Wu, Wen, Moore, Keith, Winchester, Stephen, Tu, Yuan-Po, Miller, Christopher, Kodgule, Rahul, Pendse, Amol, Rangwala, Shabbir, Joshi, Shashank
Published in The Lancet regional health. Southeast Asia (01.08.2022)
Published in The Lancet regional health. Southeast Asia (01.08.2022)
Get full text
Journal Article
An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions
Joshi, Shashank, Gudi, Girish, Menon, Vinu C. A., Tandon, Monika, Joshi, Vikas, Suryawanshi, Sachin, Barkate, Hanmant, Sawant, Nikhil, Katare, Sagar, Siddique, Waseem
Published in Clinical pharmacokinetics (01.03.2020)
Published in Clinical pharmacokinetics (01.03.2020)
Get full text
Journal Article
Correction to “SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial”
Tandon, Monika, Wu, Wen, Moore, Keith, Winchester, Stephen, Tu, Yuan-Po, Miller, Christopher, Kodgule, Rahul, Pendse, Amol, Rangwala, Shabbir, Joshi, Shashank
Published in The Lancet regional health. Southeast Asia (01.12.2022)
Published in The Lancet regional health. Southeast Asia (01.12.2022)
Get full text
Journal Article
골관절염 통증의 치료를 위한 mPGES-1 저해제
GUDI GIRISH, TANDON MONIKA, SANT SUMIT, KHAIRATKAR JOSHI NEELIMA, MENON VINU C A, TALLURI RAVI
Year of Publication 06.08.2020
Get full text
Year of Publication 06.08.2020
Patent
Comparative evaluation of US Food and Drug Administration and pharmacologically guided approaches to determine the maximum recommended starting dose for first-in-human clinical trials in adult healthy men
Imam, Md Tarique, Venkateshan, S P, Tandon, Monika, Saha, Nilanjan, Pillai, K K
Published in Journal of clinical pharmacology (01.12.2011)
Published in Journal of clinical pharmacology (01.12.2011)
Get more information
Journal Article